FourThought Financial Partners LLC Sells 159 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

FourThought Financial Partners LLC lowered its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 0.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 17,959 shares of the healthcare conglomerate’s stock after selling 159 shares during the period. FourThought Financial Partners LLC’s holdings in UnitedHealth Group were worth $9,085,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently made changes to their positions in UNH. AlphaMark Advisors LLC bought a new stake in UnitedHealth Group in the fourth quarter valued at $30,000. RPg Family Wealth Advisory LLC purchased a new stake in UnitedHealth Group during the 3rd quarter valued at about $37,000. DecisionPoint Financial LLC lifted its stake in shares of UnitedHealth Group by 155.0% in the fourth quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock worth $52,000 after buying an additional 62 shares in the last quarter. Highline Wealth Partners LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at $55,000. Finally, Legacy Investment Solutions LLC bought a new position in shares of UnitedHealth Group during the 3rd quarter valued at $57,000. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn acquired 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were bought at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Corporate insiders own 0.33% of the company’s stock.

UnitedHealth Group Trading Down 1.1 %

Shares of UnitedHealth Group stock opened at $461.09 on Tuesday. The stock has a market cap of $424.33 billion, a P/E ratio of 29.75, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock’s 50 day simple moving average is $518.52 and its 200-day simple moving average is $559.70.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company’s revenue was up 6.8% on a year-over-year basis. During the same quarter in the prior year, the company earned $5.83 earnings per share. Analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Shareholders of record on Monday, March 10th will be issued a dividend of $2.10 per share. This represents a $8.40 annualized dividend and a dividend yield of 1.82%. UnitedHealth Group’s payout ratio is 54.19%.

Analyst Upgrades and Downgrades

A number of equities analysts recently commented on UNH shares. Barclays decreased their target price on UnitedHealth Group from $655.00 to $642.00 and set an “overweight” rating on the stock in a report on Friday, January 17th. StockNews.com raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Wells Fargo & Company lowered their price objective on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a research note on Tuesday, January 28th. Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Finally, Piper Sandler dropped their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research report on Thursday, January 2nd. One analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Buy” and a consensus target price of $629.32.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.